• Something wrong with this record ?

ABO fetomaternal compatibility poses a risk for massive fetomaternal transplacental hemorrhage

Z. Zizka, T. Fait, H. Belosovicova, L. Haakova, M. Mara, M. Jirkovska, J.E. Jirasek, L. Bartosova, P. Calda

. 2008 ; 87 (10) : 1011-1014.

Language English Country Denmark

OBJECTIVE: Severe fetomaternal transplacental hemorrhage increases the risk of fetal anemia. In the third trimester, the syncytiotrophoblast becomes thinner, especially in areas where it comes into intimate contact with villous capillaries, and forms a vasculosyncytial membrane. Our aim was to determine whether ABO compatibility puts the fetus at a greater risk of severe fetomaternal hemorrhage. DESIGN: Case study. SETTING: A tertiary care center. Sample and methods. Between 2003 and 2007, we evaluated eight cases of severe fetomaternal transfusion. The Kleihauer-Betke test was used for diagnosis of fetomaternal hemorrhage. We evaluated blood group compatibility between the mother and fetus and assessed the perinatal outcome. The Fischer's factorial test was used for testing a hypothesis. RESULTS: The incidence of adverse outcomes following transplacental hemorrhage was 75% (six of eight). There were two perinatal deaths and four infants were affected by post-hypoxic damage of varying severity. Fetomaternal ABO compatibility was present in seven of the eight cases. The risk of severe fetomaternal hemorrhage was significantly increased when there was ABO compatibility between the mother and fetus. This was associated with a very poor perinatal outcome. CONCLUSION: We recommend that resuscitation in utero by intrauterine transfusion should be considered before the 33rd week of gestation in cases of severe fetal anemia. In later gestation, urgent cesarean section is required with adequate resuscitation of the newborn.

000      
02319naa 2200493 a 4500
001      
bmc11004700
003      
CZ-PrNML
005      
20241016093633.0
008      
110309s2008 dk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Žižka, Zdeněk $7 xx0074367
245    10
$a ABO fetomaternal compatibility poses a risk for massive fetomaternal transplacental hemorrhage / $c Z. Zizka, T. Fait, H. Belosovicova, L. Haakova, M. Mara, M. Jirkovska, J.E. Jirasek, L. Bartosova, P. Calda
314    __
$a 1Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic. zzizka@lf1.cuni.cz
520    9_
$a OBJECTIVE: Severe fetomaternal transplacental hemorrhage increases the risk of fetal anemia. In the third trimester, the syncytiotrophoblast becomes thinner, especially in areas where it comes into intimate contact with villous capillaries, and forms a vasculosyncytial membrane. Our aim was to determine whether ABO compatibility puts the fetus at a greater risk of severe fetomaternal hemorrhage. DESIGN: Case study. SETTING: A tertiary care center. Sample and methods. Between 2003 and 2007, we evaluated eight cases of severe fetomaternal transfusion. The Kleihauer-Betke test was used for diagnosis of fetomaternal hemorrhage. We evaluated blood group compatibility between the mother and fetus and assessed the perinatal outcome. The Fischer's factorial test was used for testing a hypothesis. RESULTS: The incidence of adverse outcomes following transplacental hemorrhage was 75% (six of eight). There were two perinatal deaths and four infants were affected by post-hypoxic damage of varying severity. Fetomaternal ABO compatibility was present in seven of the eight cases. The risk of severe fetomaternal hemorrhage was significantly increased when there was ABO compatibility between the mother and fetus. This was associated with a very poor perinatal outcome. CONCLUSION: We recommend that resuscitation in utero by intrauterine transfusion should be considered before the 33rd week of gestation in cases of severe fetal anemia. In later gestation, urgent cesarean section is required with adequate resuscitation of the newborn.
650    _2
$a ABO systém krevních skupin $x fyziologie $7 D000017
650    _2
$a intrauterinní krevní transfuze $7 D001805
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fetomaternální transfuze $x diagnóza $x etiologie $x terapie $7 D005331
650    _2
$a plod $7 D005333
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a elektronová mikroskopie $7 D008854
650    _2
$a placenta $x patofyziologie $x ultrastruktura $7 D010920
650    _2
$a těhotenství $7 D011247
650    _2
$a komplikace těhotenství $x diagnóza $x etiologie $7 D011248
650    _2
$a třetí trimestr těhotenství $7 D011263
650    _2
$a financování organizované $7 D005381
700    1_
$a Fait, Tomáš, $d 1971- $7 xx0053331
700    1_
$a Belošovičová, Hana $7 xx0323798
700    1_
$a Haaková, Lucia $7 xx0062317
700    1_
$a Mára, Michal, $d 1970- $7 xx0062099
700    1_
$a Jirkovská, Marie, $d 1954- $7 jn20000710095
700    1_
$a Jirásek, Jan Evangelista, $d 1929-2019 $7 jo20010076890
700    1_
$a Hrazdirová, Lucie $7 xx0089699
700    1_
$a Calda, Pavel, $d 1957- $7 mzk2006323882
773    0_
$t Acta Obstetricia et Gynecologica Scandinavica $w MED00009026 $g Roč. 87, č. 10 (2008), s. 1011-1014
910    __
$a ABA008 $b x $y 1 $z 0
990    __
$a 20110414093208 $b ABA008
991    __
$a 20241016093628 $b ABA008
999    __
$a ok $b bmc $g 832079 $s 696737
BAS    __
$a 3
BMC    __
$a 2008 $b 87 $c 10 $d 1011-1014 $m Acta obstetricia et gynecologica Scandinavica $n Acta Obstet Gynecol Scand $x MED00009026
LZP    __
$a 2011-4B/vtme

Find record